Delivery Order SPE2DB20D2104-SPE2DB25FNARS
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,572.79 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count packages) on September 8, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Rexulti 1 mg tablets (30-count units) with a ceiling value of $18,866.61. This non-set-aside contract award reflects a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on September 16, 2025, by the Defense Logistics Agency (DLA) for Rexulti 2 mg tablets in quantities of 30 units, with a ceiling value of $4,608.06. The contract utilizes firm fixed price pricing and is scheduled for ultimate completion by September 17, 2025. This delivery order was issued without a set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,927.61 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rexulti 2 mg tablets (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rexulti 1 mg tablets (30-count package) valued at $9,576.43 under a firm fixed-price contract. This non-set-aside award represents a competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rexulti 2 mg tablets (30-count units) with a ceiling value of $62,432.04. This firm fixed-price delivery order, which is due for completion by September 17, 2025, represents a competitively awarded contract with no set-aside designation. The award leverages AmerisourceBergen's established relationship with DLA as a critical pharmaceutical supplier supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,937.85 to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 3 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a $10,602.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units), with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $33,428.28 by the Defense Logistics Agency on September 3, 2025, for the supply of Rexulti 1 mg tablets in a 30-count package. The contract is classified as Firm Fixed Price with an ultimate completion date of September 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...